Log in

FRA:FREFresenius SE & Co KGaA Stock Price, Forecast & News

€43.20
+0.05 (+0.12 %)
(As of 06/2/2020 01:55 AM ET)
Add
Compare
Today's Range
€42.38
Now: €43.20▼
€43.39
50-Day Range
€36.39
MA: €39.82▼
€44.61
52-Week Range
€60.16
Now: €43.20▼
€80.00
Volume3.11 million shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Fresenius SE & Co. KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment offers dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment specializes in the therapy and care of chronically and critically ill patients. This segment offers IV drugs, including intravenously administered generic anesthetics, analgesics, anti-infectives, and drugs for the treatment of oncological and other critical diseases; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; infusion and nutrition pumps, as well as consumables; and products that are used in the collection and processing of blood components, as well as in transfusion medicine and cell therapy. As of December 31, 2019, this segment operated 86 hospitals, approximately 125 outpatient clinics, and 8 prevention centers. The Fresenius Vamed segment manages projects and provides services for hospitals and other health care facilities. This segment offers project development, planning, and turnkey construction services, as well as maintenance, technical management, and operational management services. Fresenius SE & Co. KGaA has a strategic partnership with Humacyte Inc. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.
Read More
Fresenius SE & Co KGaA logo

Beat the Market (BTM) Rank™

Analyst Opinion: 3.3Community Rank: 3.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

1.28 out of 5 stars


Industry, Sector and Symbol

Stock Exchange FRA
Industry Medical Care Facilities
Sub-IndustryN/A
SectorMedical
Current SymbolFRA:FRE
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.fresenius.de
Phone+49-6172-6080

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Employees299,594
Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable
FRE Rates by TradingView

Receive FRE News and Ratings via Email

Sign-up to receive the latest news and ratings for FRE and its competitors with MarketBeat's FREE daily newsletter.

Fresenius SE & Co KGaA (FRA:FRE) Frequently Asked Questions

How has Fresenius SE & Co KGaA's stock been impacted by COVID-19 (Coronavirus)?

Fresenius SE & Co KGaA's stock was trading at €36.02 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, FRE shares have increased by 19.9% and is now trading at €43.20. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Fresenius SE & Co KGaA?

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fresenius SE & Co KGaA in the last year. There are currently 6 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Fresenius SE & Co KGaA.

What price target have analysts set for FRE?

16 brokerages have issued 1-year price objectives for Fresenius SE & Co KGaA's stock. Their forecasts range from €37.00 to €66.30. On average, they expect Fresenius SE & Co KGaA's share price to reach €51.85 in the next twelve months. This suggests a possible upside of 20.0% from the stock's current price. View analysts' price targets for Fresenius SE & Co KGaA.

Has Fresenius SE & Co KGaA been receiving favorable news coverage?

Media coverage about FRE stock has been trending very positive recently, according to InfoTrie Sentiment Analysis. InfoTrie scores the sentiment of press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Fresenius SE & Co KGaA earned a coverage optimism score of 3.5 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View the latest news aboutFresenius SE & Co KGaA.

Who are some of Fresenius SE & Co KGaA's key competitors?

What other stocks do shareholders of Fresenius SE & Co KGaA own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Fresenius SE & Co KGaA investors own include Illumina (ILMN), Endologix (ELGX), Daimler (DAI), Cambrex (CBM), Apache (APA), General Electric (GE), Hudbay Minerals (HBM), Linde (LIN), Prudential (PRU) and Rio Tinto (RIO).

Who are Fresenius SE & Co KGaA's key executives?

Fresenius SE & Co KGaA's management team includes the following people:
  • Mr. Stephan Sturm, CEO, Pres & Chairman of Management Board - Fresenius Management SE (Age 57, Pay $3.49M)
  • Ms. Rachel Clare Empey, CFO & Member of Management Board - Fresenius Management SE (Age 44, Pay $1.61M)
  • Dr. Francesco De Meo, Member of Management Board - Fresenius Management SE (Age 57, Pay $2.4M)
  • Dr. Jürgen Götz, Chief Legal & Compliance Officer & Labor Relations Director and Member of Management Board - GP (Age 56, Pay $1.76M)
  • Dr. Ernst Wastler, Member of Management Board - Fresenius Management SE (Age 62, Pay $1.43M)

What is Fresenius SE & Co KGaA's stock symbol?

Fresenius SE & Co KGaA trades on the FRA under the ticker symbol "FRE."

What is Fresenius SE & Co KGaA's stock price today?

One share of FRE stock can currently be purchased for approximately €43.20.

What is Fresenius SE & Co KGaA's official website?

The official website for Fresenius SE & Co KGaA is www.fresenius.de.

How can I contact Fresenius SE & Co KGaA?

Fresenius SE & Co KGaA's mailing address is Else-Kroener-Str. 1, BAD HOMBURG VOR DER HOEHE, 61352, Germany. The company can be reached via phone at +49-6172-6080.

This page was last updated on 6/2/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.